HYAL2 and lung carcinoma: However, HYAL2 mutations were not identified in 40 lung cancer cell lines and overexpression of HYAL2 in 4 chromosome 3p-deficient lung cancer cell lines did not alter cell proliferation or apoptosis rates [24].